A. Trampuz et al., Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid, ANTIM AG CH, 44(5), 2000, pp. 1352-1355
The pharmacokinetics of levofloxacin in serum and in skin blister fluid (SB
F) was determined for 20 volunteers after a single 500-mg oral dose of levo
floxacin. In addition, ex vivo bactericidal activity of SBF against Strepto
coccus pneumoniae and Staphylococcus aureus was studied. SBF containing lev
ofloxacin and granulocytes killed 5.2 log of Streptococcus pneumoniae bacte
ria and 2.0 log of Staphylococcus aureus bacteria during a 6-h incubation.